20 related articles for article (PubMed ID: 38461905)
1. The potential contribution of aberrant cathepsin K expression to gastric cancer pathogenesis.
Feng Z; Gao L; Lu Y; He X; Xie J
Discov Oncol; 2024 Jun; 15(1):218. PubMed ID: 38856944
[TBL] [Abstract][Full Text] [Related]
2. Histone Lactylation Drives CD8 T Cell Metabolism and Function.
Raychaudhuri D; Singh P; Hennessey M; Chakraborty B; Tannir AJ; Trujillo-Ocampo A; Im JS; Goswami S
bioRxiv; 2024 Jun; ():. PubMed ID: 38854142
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
4. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
[TBL] [Abstract][Full Text] [Related]
5. Adenosine interaction with adenosine receptor A2a promotes gastric cancer metastasis by enhancing PI3K-AKT-mTOR signaling.
Shi L; Wu Z; Miao J; Du S; Ai S; Xu E; Feng M; Song J; Guan W
Mol Biol Cell; 2019 Sep; 30(19):2527-2534. PubMed ID: 31339445
[TBL] [Abstract][Full Text] [Related]
6. CDK12 Promotes the Proliferation, Migration, and Angiogenesis of Gastric Carcinoma via Activating the PI3K/AKT/mTOR Signaling Pathway.
Gao LZ; Wang JQ; Chen JL; Zhang XL; Zhang MM; Wang SL; Zhao C
Appl Biochem Biotechnol; 2023 Nov; 195(11):6913-6926. PubMed ID: 36951936
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway.
Wang C; Yang Z; Xu E; Shen X; Wang X; Li Z; Yu H; Chen K; Hu Q; Xia X; Liu S; Guan W
Clin Transl Med; 2021 Aug; 11(8):e522. PubMed ID: 34459127
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Significance and Involvement in Molecular Cancer Processes of Chemokine CXCL1 in Selected Tumors.
Korbecki J; Bosiacki M; Szatkowska I; Kupnicka P; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673949
[TBL] [Abstract][Full Text] [Related]
9. H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mTOR-CXCL1 axis.
Zhao Y; Jiang J; Zhou P; Deng K; Liu Z; Yang M; Yang X; Li J; Li R; Xia J
Biochem Pharmacol; 2024 Apr; 222():116120. PubMed ID: 38461905
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration.
Jin J; Zhao Q
Theranostics; 2020; 10(14):6231-6244. PubMed ID: 32483450
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]